Trial Profile
A phase I/II trial of induction chemotherapy plus gefitinib (Iressa) followed by concurrent chemotherapy, radiation therapy, and gefitinib (Iressa) for patients with locally advanced squamous carcinoma of the head and neck
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 25 Nov 2013
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary) ; Gefitinib (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 22 Oct 2007 New trial centre added.
- 22 Feb 2006 New trial record.